Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment

Arch Dermatol. 2012 Nov;148(11):1332-3. doi: 10.1001/archdermatol.2012.2958.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Mycobacterium tuberculosis / isolation & purification
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Recurrence
  • Severity of Illness Index
  • Tuberculosis, Lymph Node / drug therapy
  • Tuberculosis, Lymph Node / epidemiology*
  • Tuberculosis, Lymph Node / etiology
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents
  • Dermatologic Agents
  • Ustekinumab